QBIOOTCHealthcare · Biotechnology

Q BioMed Inc.

$0.00-0.00%($-0.00)

TickerSpark Score

54/100

Mixed

100

Valuation

Profitability

100

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QBIO research report →

52-Week Range0% of range

Low $0.00

Current $0.00

High $0.03

Companywww.qbiomed.com

Q BioMed Inc. , a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.

CEO: Denis D. Corin
IPO: 2015
Employees: 3
HQ: New York City, NY, US

Price Chart

+9900.00% · this period

Valuation

Market Cap: $14.51K
P/E: -0.00
P/S: 0.05
P/B: -0.00
EV/EBITDA: -6.60
Div Yield: 0.00%

Profitability

Gross Margin: -3.16%
Op Margin: -1211.74%
Net Margin: -721.67%
ROE: 44.12%
ROIC: 679.02%

Growth & Income

Revenue: $284.35K · 45.38%
Net Income: $-2,052,093 · 75.10%
EPS: $-0.08 · 76.33%
Op Income: $-3,445,616
FCF YoY: 145.13%

Performance & Tape

52W High: $0.03
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -154.93
Avg Volume: 376

Get TickerSpark's AI analysis on QBIO

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
May 26, 22	Corin Denis	officer: Chief Executive Officer	other	200,000	$4.00B
Feb 1, 21	Rosenstadt William S	director, 10 percent owner, officer: Chief Legal Officer	other	35,000	$0
Oct 27, 20	Corin Denis	director, 10 percent owner, officer: Chief Executive Officer	other	500,000	$515.00K
Aug 29, 20	Corin Denis	director, 10 percent owner, officer: Chief Executive Officer	other	150,000	$225.00K
Aug 29, 20	Corin Denis	director, 10 percent owner, officer: Chief Executive Officer	other	150,000	$225.00K
Oct 27, 20	Rosenstadt William S	director, 10 percent owner, officer: Chief Legal Officer	other	500,000	$515.00K
Aug 29, 20	Rosenstadt William S	director, 10 percent owner, officer: Chief Legal Officer	other	150,000	$225.00K
Aug 29, 20	Rosenstadt William S	director, 10 percent owner, officer: Chief Legal Officer	other	150,000	$225.00K
Apr 6, 20	Rosenstadt William S	director, 10 percent owner, officer: Chief Legal Officer	other	225,000	$477.00K
Feb 10, 20	Corin Denis	director, 10 percent owner, officer: Chief Executive Officer	other	750,000	$1.59M